Reasons for the degeneration of ageing skeletal muscle: A central role for IGF-1 signalling

Biogerontology

Volumn 3, Issue 1-2, 2002, Pages 19-24

  Grounds, Miranda D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Ageing; Atrophy; Denervation; Hypertrophy; IGF 1; Motorneurone death; Regeneration; Skeletal muscle

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; CYTOKINE; DEXAMETHASONE; GROWTH HORMONE; INSULIN; INTERLEUKIN 6; ISOPROTEIN; SOMATOMEDIN C; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

AGING; ANIMAL CELL; ARTICLE; CACHEXIA; CELL DEATH; CELL LOSS; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOTONEURON; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE EXERCISE; MUSCLE HYPERTROPHY; MUSCLE INNERVATION; MUSCLE MASS; MUSCLE REGENERATION; MUSCLE STRENGTH; NEUROPATHY; NONHUMAN; NUTRITION; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; VITAMIN D DEFICIENCY;

AGE FACTORS; AGING; ANIMALS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MUSCLE, SKELETAL; REGENERATION; SIGNAL TRANSDUCTION;

EID: 0036203972     PISSN: 13895729     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015234709314     Document Type: Article

References (47)

1. The divergent effects of tumour necrosis factor-alpha on skeletal muscle: Implications in wasting
2. Cancer cachexia: A therapeutic approach
3. Muscle fibre branching: Differences between grafts in young and old rats
4. Viral mediated expression of insulin-like growth factor I blocks the age-related loss of skeletal muscle function
5. Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle
6. Predictors of skeletal muscle mass in elderly men and women
7. The effect of anabolic steroids and corticosteroids on healing of muscle contusion injury
8. A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis
9. The magnitude of the initial injury induced by stretches of maximally activated muscle fibers of mice and rats increases with old age
10. At the interface of environmental-immune interactions: Cytokine and growth factor receptors
11. Activation of Src kinase in skeletal muscle cells by 1,1,25-(OH(2))-vitaminD(3) correlates with tyrosine phosphorylation of the vitamin D receptor (VDR) and VDR-Src interaction
12. Skeletal muscle regeneration in very old rats
13. Muscle regeneration in young and old rats: Effects of motor nerve transection with and without marcaine treatment
14. The anorexia of ageing
15. From Charcot to SOD1: Mechanisms of selective motor neuron death in ALS
16. Regeneration of new fibres in muscles of old rats reduces contraction-induced injury
17. Vitamin D deficiency and aging: Implications for general health and osteoporosis
18. Muscle atrophy and weakness with aging: Contraction-induced injury as an underlying mechanism
19. The insulin-like growth factor signaling system and ALS neurotrophic factor treatment strategies
20. Transient exposure of human myoblasts to tumour necrosis factor-α inhibits serum and insulin-like growth factor-I stimulated protein synthesis
21. Acute treatment with corticosteroids decreases IGF-1 and IGF-2 expression in the rat diaphragm and gastrocnemius
22. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting
23. Towards understanding skeletal muscle regeneration
24. Age-Associated changes in the response of skeletal muscle cells to exercise and regeneration
25. Beneficial effects of insulin-like growth factor-I on wobbler mouse motoneuron disease
26. Examining potential drug therapies for muscular dystrophy utilising the dy/dy mouse: 1. Clenbuterol
27. Insulin-like growth factor-I: Potential for treatment of motor neuronal disorders
28. Age-associated changes in the innervation of muscle fibres and changes in the mechanical properties of motor units
29. Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation
30. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member
31. Gigantism in mice lacking suppressor of cytokine signalling-2
32. Clinical trials in motorneuron disease
33. Localized IGF-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle
34. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1
35. Src phorphorylates the insulin-like growth factor type I receptor on the autophosporylation sites. Requirement for transformation by src
36. Body composition, Sex steroids, IGF-I, and bone-mineral status in aging men
37. Gamma-Irradiation Prevents Compensatory Hypertrophy of Overloaded Mouse Extensor Digitorum Longus Muscle
38. Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct
39. Dexamethasone inhibits insulin-like growth factor signaling and potentiates myoblast apoptosis
40. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice
41. Interaction of the Ski Oncoprotein with Smad3 regulates TGF-β signalling
42. Protein and Amino Acid Metabolism in Muscle
43. Space travel directly induces skeletal muscle atrophy
44. Glycosaminoglycans boost insulin-like growth factor-I-promoted neuroprotection: Blockade of motor neuron death in the wobbler mouse
45. Muscle strength, functional mobility and vitamin D in older women
46. Regulation of C. elegans life-span by insulinlike signaling in the nervous system
47. Dominant negative myostatin produces hypertrophy without hyperplasia in muscle